Hypertension Clinical Trials

Showing 2841-2860 of 3,518 trials

Identifying Genes Involved in Abnormal Blood Pressure - Hypertension SCOR

NCT00005325

To seek out genes or genetic markers which identify subjects more vulnerable to hypertension under the influence of environmental factors.

Cardiovascular DiseasesHeart DiseasesHypertension

Boston UniversityStarted Feb 1996

COMPLETEDPhase 3

Safety and Efficacy of Travoprost/Timolol BAC-free

NCT00760539

The purpose of this study is to demonstrate equivalent safety and IOP-lowering effectiveness of two Travoprost/Timolol combination products in patients diagnosed with open-angle glaucoma or ocular hypertension. This global study will be conducted in the US (C-07-64, NCT00672997) and Japan (C-08-08, NCT00760539).

Open-Angle GlaucomaOcular Hypertension

Alcon Research87 participantsStarted Jun 2008

Hamura, Tokyo, Japan

COMPLETEDPhase 3

A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT00672997

Open-Angle GlaucomaOcular Hypertension

Alcon Research301 participantsStarted May 2008

COMPLETEDPhase 3

Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health

NCT00892762

The purpose of this study is to understand differences in visual function-related patient-reported outcomes between a non-BAK medication (Travoprost APS) and a BAK-preserved medication (XALATAN®) in patients with open-angle glaucoma or ocular hypertension.

Open Angle GlaucomaOcular Hypertension

Alcon Research434 participantsStarted Jun 2009

Identifying Genes Involved in Abnormal Blood Pressure - Hypertension SCOR

Safety and Efficacy of Travoprost/Timolol BAC-free

A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension

Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health

Related Searches

Pharmacokinetics of BIBR 277 in Hypertensive Patients

Patient Preference Study

Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension

Telmisartan Compared With Enalapril in Elderly Patients With Blood Hypertension

Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH)

Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate Hypertension

Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension

Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia

Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan Monotherapy

Phase 4 Study to Assess the Effect of Bisoprolol on Glycemic Level in Type II Diabetic Subjects With Suboptimal Blood Pressure Control

Effects of Intralipid Versus Olive Oil Infusions on Endothelial Function, Immune Function, Inflammatory Markers

Exercise and Respiratory Training as Supportive Treatments for Patients With Chronic Pulmonary Hypertension

Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada

Efficacy and Safety of Telmisartan in Hypertensive Patients With Mild/Moderate or Severe Renal Impairment or Requiring Hemodialysis

Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary Hypertension

An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination